256 related articles for article (PubMed ID: 17227274)
1. Heparin-induced thrombocytopenia without thrombosis: an evidence-based review of current literature.
O'Connor ED; Fraser JF
Crit Care Resusc; 2006 Dec; 8(4):345-52. PubMed ID: 17227274
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
Jeske WP; Walenga JM
Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
[TBL] [Abstract][Full Text] [Related]
3. Current agents for the treatment of patients with heparin-induced thrombocytopenia.
Warkentin TE
Curr Opin Pulm Med; 2002 Sep; 8(5):405-12. PubMed ID: 12172444
[TBL] [Abstract][Full Text] [Related]
4. The management of heparin-induced thrombocytopenia.
Keeling D; Davidson S; Watson H;
Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
[TBL] [Abstract][Full Text] [Related]
5. [Heparin-induced thrombocytopenia].
Christoffersen C; Lethagen S; Gøtze JP
Ugeskr Laeger; 2009 Feb; 171(8):612-5. PubMed ID: 19284907
[TBL] [Abstract][Full Text] [Related]
6. Preventing complications in heparin-induced thrombocytopenia. Alternative anticoagulants are improving patient outcomes.
Rice L; Nguyen PH; Vann AR
Postgrad Med; 2002 Sep; 112(3):85-9. PubMed ID: 12360660
[TBL] [Abstract][Full Text] [Related]
7. Heparin-induced thrombocytopenia in the critical care setting: diagnosis and management.
Napolitano LM; Warkentin TE; Almahameed A; Nasraway SA
Crit Care Med; 2006 Dec; 34(12):2898-911. PubMed ID: 17075368
[TBL] [Abstract][Full Text] [Related]
8. Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.
Schindewolf M; Steindl J; Beyer-Westendorf J; Schellong S; Dohmen PM; Brachmann J; Madlener K; Pötzsch B; Klamroth R; Hankowitz J; Banik N; Eberle S; Müller MM; Kropff S; Lindhoff-Last E
J Am Coll Cardiol; 2017 Nov; 70(21):2636-2648. PubMed ID: 29169470
[TBL] [Abstract][Full Text] [Related]
9. Heparin-induced thrombocytopenia in intensive care patients.
Selleng K; Warkentin TE; Greinacher A
Crit Care Med; 2007 Apr; 35(4):1165-76. PubMed ID: 17334253
[TBL] [Abstract][Full Text] [Related]
10. Heparin-induced thrombocytopenia: what clinicians need to know.
Chong BH; Isaacs A
Thromb Haemost; 2009 Feb; 101(2):279-83. PubMed ID: 19190810
[No Abstract] [Full Text] [Related]
11. New treatment options for heparin-induced thrombocytopenia.
Ortel TL; Chong BH
Semin Hematol; 1998 Oct; 35(4 Suppl 5):26-34; discussion 35-6. PubMed ID: 9855181
[TBL] [Abstract][Full Text] [Related]
12. Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia.
Lassila R; Antovic JP; Armstrong E; Baghaei F; Dalsgaard-Nielsen J; Hillarp A; Holme PA; Holmström M; Johnsson H; Joutsi-Korhonen L; Sandset PM
Semin Thromb Hemost; 2011 Apr; 37(3):328-36. PubMed ID: 21455867
[TBL] [Abstract][Full Text] [Related]
13. Heparin-induced thrombocytopaenia.
Prince M; Wenham T
Postgrad Med J; 2018 Aug; 94(1114):453-457. PubMed ID: 30126928
[TBL] [Abstract][Full Text] [Related]
14. Argatroban, a new treatment option for heparin-induced thrombocytopenia.
Cleveland KW
Crit Care Nurse; 2003 Dec; 23(6):61-6. PubMed ID: 14692173
[No Abstract] [Full Text] [Related]
15. Heparin-induced thrombocytopenia in paediatric patients--a review of the literature and a new case treated with danaparoid sodium.
Ranze O; Ranze P; Magnani HN; Greinacher A
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S130-3. PubMed ID: 10650852
[TBL] [Abstract][Full Text] [Related]
16. Heparin-induced thrombocytopenia (HIT): in vitro and in vivo cross-reactivity to danaparoid sodium and successful treatment with recombinant hirudin (lepirudin).
Baumgärtel MW; Eichler P; Glöckner WM; Ranze O; Greinacher A
Eur J Haematol; 2000 Aug; 65(2):148-9. PubMed ID: 10966178
[No Abstract] [Full Text] [Related]
17. Heparin-induced thrombocytopenia and cardiovascular diseases.
Das P; Ziada K; Steinhubl SR; Moliterno DJ; Hamdalla H; Jozic J; Mukherjee D
Am Heart J; 2006 Jul; 152(1):19-26. PubMed ID: 16824828
[No Abstract] [Full Text] [Related]
18. Treatment of heparin-induced thrombocytopenia in cardiovascular patients.
Matthai WH
Expert Opin Pharmacother; 2006 Feb; 7(3):267-76. PubMed ID: 16448321
[TBL] [Abstract][Full Text] [Related]
19. Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.
Lubenow N; Greinacher A
J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():47-57. PubMed ID: 11155194
[No Abstract] [Full Text] [Related]
20. Heparin-induced thrombocytopenia: pathophysiology and management.
Mureebe L; Silver D
Vasc Endovascular Surg; 2002; 36(3):163-70. PubMed ID: 12075381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
